Helius Medical Technologies Stock Performance
| HSDT Stock | USD 0.40 0.01 2.44% |
The company retains a Market Volatility (i.e., Beta) of 1.13, which attests to a somewhat significant risk relative to the market. Helius Medical returns are very sensitive to returns on the market. As the market goes up or down, Helius Medical is expected to follow. At this point, Helius Medical Techn has a negative expected return of -0.81%. Please make sure to check out Helius Medical's potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if Helius Medical Techn performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Helius Medical Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 14.5 M |
Helius |
Helius Medical Relative Risk vs. Return Landscape
If you would invest 81.00 in Helius Medical Technologies on December 26, 2024 and sell it today you would lose (41.00) from holding Helius Medical Technologies or give up 50.62% of portfolio value over 90 days. Helius Medical Technologies is currently does not generate positive expected returns and assumes 8.652% risk (volatility on return distribution) over the 90 days horizon. In different words, 77% of stocks are less volatile than Helius, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Helius Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Helius Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Helius Medical Technologies, and traders can use it to determine the average amount a Helius Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0934
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | HSDT |
Estimated Market Risk
| 8.65 actual daily | 77 77% of assets are less volatile |
Expected Return
| -0.81 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Helius Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Helius Medical by adding Helius Medical to a well-diversified portfolio.
Helius Medical Fundamentals Growth
Helius Stock prices reflect investors' perceptions of the future prospects and financial health of Helius Medical, and Helius Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Helius Stock performance.
| Return On Equity | -2.6 | ||||
| Return On Asset | -1.13 | ||||
| Operating Margin | (79.80) % | ||||
| Current Valuation | (1.11 M) | ||||
| Shares Outstanding | 5.67 M | ||||
| Price To Earning | (13.85) X | ||||
| Price To Book | 0.61 X | ||||
| Price To Sales | 4.65 X | ||||
| Revenue | 644 K | ||||
| EBITDA | (12.11 M) | ||||
| Cash And Equivalents | 3.27 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 57 K | ||||
| Debt To Equity | 0.03 % | ||||
| Book Value Per Share | 1.04 X | ||||
| Cash Flow From Operations | (10.42 M) | ||||
| Earnings Per Share | (4.27) X | ||||
| Total Asset | 7.69 M | ||||
| Retained Earnings | (159.96 M) | ||||
| Current Asset | 6.8 M | ||||
| Current Liabilities | 4.46 M | ||||
About Helius Medical Performance
Assessing Helius Medical's fundamental ratios provides investors with valuable insights into Helius Medical's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Helius Medical is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator , is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.Things to note about Helius Medical Techn performance evaluation
Checking the ongoing alerts about Helius Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Helius Medical Techn help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Helius Medical Techn generated a negative expected return over the last 90 days | |
| Helius Medical Techn has high historical volatility and very poor performance | |
| Helius Medical Techn has some characteristics of a very speculative penny stock | |
| Helius Medical Techn has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 644 K. Net Loss for the year was (8.85 M) with loss before overhead, payroll, taxes, and interest of (16 K). | |
| Helius Medical Technologies currently holds about 3.27 M in cash with (10.42 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.12. |
- Analyzing Helius Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Helius Medical's stock is overvalued or undervalued compared to its peers.
- Examining Helius Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Helius Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Helius Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Helius Medical's stock. These opinions can provide insight into Helius Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Helius Stock Analysis
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.